Shinichiro Toki

2.2k total citations · 1 hit paper
28 papers, 1.9k citations indexed

About

Shinichiro Toki is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Shinichiro Toki has authored 28 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Pharmacology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Shinichiro Toki's work include Neuroscience and Neuropharmacology Research (7 papers), Amino Acid Enzymes and Metabolism (6 papers) and Microbial metabolism and enzyme function (4 papers). Shinichiro Toki is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Amino Acid Enzymes and Metabolism (6 papers) and Microbial metabolism and enzyme function (4 papers). Shinichiro Toki collaborates with scholars based in Japan, Singapore and United States. Shinichiro Toki's co-authors include David E. Housman, Ann M. Graybiel, Gregory M. Springett, Naoki Mochizuki, Michiyuki Matsuda, Hiroaki Kawasaki, Mie Nakaya, Yuzuru Matsuda, Justin P. Blumenstiel and Juan J. Canales and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Shinichiro Toki

28 papers receiving 1.8k citations

Hit Papers

A Family of cAMP-Binding Proteins That Directly Activate ... 1998 2026 2007 2016 1998 250 500 750 1000

Peers

Shinichiro Toki
F R McKenzie United Kingdom
K. Naito Japan
Craig E. Crosson United States
W. Howard Evans United Kingdom
Carole L. Jelsema United States
Shinichiro Toki
Citations per year, relative to Shinichiro Toki Shinichiro Toki (= 1×) peers Shunji Ohsako

Countries citing papers authored by Shinichiro Toki

Since Specialization
Citations

This map shows the geographic impact of Shinichiro Toki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Toki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Toki more than expected).

Fields of papers citing papers by Shinichiro Toki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichiro Toki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Toki. The network helps show where Shinichiro Toki may publish in the future.

Co-authorship network of co-authors of Shinichiro Toki

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichiro Toki. A scholar is included among the top collaborators of Shinichiro Toki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichiro Toki. Shinichiro Toki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugimoto, Yoshiyuki, Kiyotoshi Mori, Hiroshi Ishida, et al.. (2013). K-685, a TRPV1 Antagonist, Blocks PKC-Sensitized TRPV1 Activation and Improves the Inflammatory Pain in a Rat Complete Freund’s Adjuvant Model. Journal of Pharmacological Sciences. 123(3). 256–266. 9 indexed citations
2.
Furuse, Tamio, Kotaro Hattori, Ikuko Yamada, et al.. (2010). Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis. European Journal of Neuroscience. 31(7). 1281–1291. 26 indexed citations
3.
Hirose, Ryo, et al.. (2009). Diamine Derivatives Containing Imidazolidinylidene Propanedinitrile as a New Class of Histamine H3 Receptor Antagonists: Conformationally Restricted Derivatives. Chemical and Pharmaceutical Bulletin. 57(3). 288–293. 2 indexed citations
4.
Hirose, Ryo, et al.. (2008). Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I. Bioorganic & Medicinal Chemistry Letters. 18(7). 2288–2291. 8 indexed citations
5.
Toki, Shinichiro, Hiroaki Kawasaki, Nobutada Tashiro, David E. Housman, & Ann M. Graybiel. (2001). Guanine nucleotide exchange factors CalDAG‐GEFI and CalDAG‐GEFII are colocalized in striatal projection neurons. The Journal of Comparative Neurology. 437(4). 398–407. 28 indexed citations
6.
Toki, Shinichiro, Tsutomu Agatsuma, Keiko Ochiai, et al.. (2001). RP-1776, a Novel Cyclic Peptide Produced by Streptomyces sp., Inhibits the Binding of PDGF to the Extracellular Domain of Its Receptor.. The Journal of Antibiotics. 54(5). 405–414. 45 indexed citations
7.
Toki, Shinichiro, Takeo Tanaka, Youichi Uosaki, et al.. (1999). RP-1551s, a Family of Azaphilones Produced by Penicillium sp., Inhibit the Binding of PDGF to the Extracellular Domain of Its Receptor.. The Journal of Antibiotics. 52(3). 235–244. 21 indexed citations
8.
Yano, Keiichi, Shinichiro Toki, Keiko Ochiai, et al.. (1996). MS-271, a novel inhibitor of calmodulin-activated myosin light chain kinase from Streptomyces sp.—I. isolation, structural determination and biological properties of MS-271. Bioorganic & Medicinal Chemistry. 4(1). 115–120. 37 indexed citations
9.
Nakanishi, Satoshi, et al.. (1995). Isolation of Myosin Light Chain Kinase Inhibitors from Microorganisms: Dehydroaltenusin, Altenusin, Atrovenetinone, and Cyclooctasulfur. Bioscience Biotechnology and Biochemistry. 59(7). 1333–1335. 48 indexed citations
10.
Toki, Shinichiro, Mayumi Yoshida, Katsuhiko Ando, & Yuzuru Matsuda. (1995). PS-990, a Novel Microbial Metabolite, Reversibly Induces Neurite Extension in Neuroblastoma Cells. Bioscience Biotechnology and Biochemistry. 59(7). 1281–1286. 1 indexed citations
12.
Toki, Shinichiro, et al.. (1994). PS-990, a novel neuritogenic compound from Acremonium sp.. The Journal of Antibiotics. 47(11). 1175–1181. 10 indexed citations
13.
Toki, Shinichiro, et al.. (1993). Neurite formation in NG108-15 neuroblastoma*glioma hybrid cells by KS-505a, a potent inhibitor of brain Cyclic nucleotide phosphodiesterase.. The Journal of Antibiotics. 46(9). 1481–1483. 5 indexed citations
14.
Toki, Shinichiro, et al.. (1993). The neuroprotective properties of ES-242s, novel NMDA receptor antagonists, in neuronal cell culture toxicity studies. European Journal of Pharmacology. 236(2). 263–268. 4 indexed citations
15.
Toki, Shinichiro, Katsuhiko Ando, Mayumi Yoshida, et al.. (1992). ES-242-1, a novel compound from Verticillium sp., binds to a site on N-methyl-D-aspartate receptor that is coupled to the channel domain.. The Journal of Antibiotics. 45(1). 88–93. 19 indexed citations
16.
Toki, Shinichiro, et al.. (1992). HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells. Neuroscience Letters. 135(1). 117–120. 23 indexed citations
17.
Toki, Shinichiro, Katsuhiko Ando, Isao Kawamoto, et al.. (1992). ES-242-2, -3, -4, -5, -6, -7, and -8, novel bioxanthracenes produced by Verticillium sp., which act on the N-methyl-D-aspartate receptor.. The Journal of Antibiotics. 45(7). 1047–1054. 22 indexed citations
18.
Toki, Shinichiro, et al.. (1987). Further characterization of serine hydroxymethyltransferase from a serine-producing methylotroph, Hyphomicrobium methylovorum.. Agricultural and Biological Chemistry. 51(9). 2587–2589. 4 indexed citations
19.
Toki, Shinichiro, et al.. (1987). Further Characterization of Serine Hydroxymethyltransferase from a Serine-producing Methylotroph,Hyphomicrobium methylovorum. Agricultural and Biological Chemistry. 51(9). 2587–2589. 1 indexed citations
20.
Toki, Shinichiro, et al.. (1986). Crystalline serine hydroxymethyltransferase from an obligate methylotroph, Hyphomicrobium methylovorum. Biochemical and Biophysical Research Communications. 139(1). 71–78. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026